secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZIMMER BIOMET HOLDINGS, INC. (ZBH)
CIK:        0001136869
Form:       8-K
Filed at:   2025-05-27T23:59:59+00:00
Accession:  0001193125-25-126231
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zimmer Biomet appoints Kevin Thornal as Group President, Global Businesses and the Americas effective July 1, 2025
--------------------------------------------------------------------------------

- Thornal appointed to new role effective July 1; reports to CEO Ivan Tornos, leads Americas and global business units.
- Former Nevro CEO and Hologic Group President; previously held leadership at Stryker.
- Mark Bezjak remains President Americas but ceases as executive officer upon Thornal's start.
- Compensation: $850k base, 100% target bonus, ~$5.3M in equity (RSUs + PRSUs); eligible for severance plans.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1136869/000119312525126231/0001193125-25-126231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1136869/000119312525126231/d854072d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-126231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer